The Future of Somatostatin Receptor Ligands in Acromegaly

Monica R Gadelha, Luiz Eduardo Wildemberg, Leandro Kasuki

Open source

DOI
10.1210/clinem/dgab726
Published
2021-10-07
Container
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1210/clinem/dgab726,
  title = {The Future of Somatostatin Receptor Ligands in Acromegaly},
  author = {Monica R Gadelha and Luiz Eduardo Wildemberg and Leandro Kasuki},
  year = {2021},
  journal = {The Journal of Clinical Endocrinology \& Metabolism},
  doi = {10.1210/clinem/dgab726},
  url = {https://doi.org/10.1210/clinem/dgab726}
}

RIS

TY  - JOUR
TI  - The Future of Somatostatin Receptor Ligands in Acromegaly
AU  - Monica R Gadelha
AU  - Luiz Eduardo Wildemberg
AU  - Leandro Kasuki
PY  - 2021
JO  - The Journal of Clinical Endocrinology & Metabolism
DO  - 10.1210/clinem/dgab726
UR  - https://doi.org/10.1210/clinem/dgab726
ER  - 

APA

Gadelha, M. R., Wildemberg, L. E., & Kasuki, L. (2021). The Future of Somatostatin Receptor Ligands in Acromegaly. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgab726

Source records